Gilead says Glaxo venture’s HIV patent invalid
Intellectual Property 2019-12-10 11:57 pm | Melbourne
US biotech giant Gilead has struck back at a patent infringement lawsuit brought by a specialist HIV pharmaceutical company majority owned by GlaxoSmithKline, saying the patent at the centre of the lawsuit is invalid.
For information on rights and reprints, contact subscriptions@lawyerly.com.au